A Novel Artificial Coronary Plaque to Model Coronary Heart Disease.

atherosclerosis coronary heart disease plaque

Journal

Biomimetics (Basel, Switzerland)
ISSN: 2313-7673
Titre abrégé: Biomimetics (Basel)
Pays: Switzerland
ID NLM: 101719189

Informations de publication

Date de publication:
26 Mar 2024
Historique:
received: 11 02 2024
revised: 16 03 2024
accepted: 20 03 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 26 4 2024
Statut: epublish

Résumé

Experimental coronary artery interventions are currently being performed on non-diseased blood vessels in healthy animals. To provide a more realistic pathoanatomical scenario for investigations on novel interventional and surgical therapies, we aimed to fabricate a stenotic lesion, mimicking the morphology and structure of a human atherosclerotic plaque. In an interdisciplinary setting, we engineered a casting mold to create an atherosclerotic plaque with the dimensions to fit in a porcine coronary artery. Oscillatory rheology experiments took place along with long-term stability tests assessed by microscopic examination and weight monitoring. For the implantability in future in vivo setups, we performed a cytotoxicity assessment, inserted the plaque in resected pig hearts, and performed diagnostic imaging to visualize the plaque in its final position. The most promising composition consists of gelatin, cholesterol, phospholipids, hydroxyapatite, and fine-grained calcium carbonate. It can be inserted in the coronary artery of human-sized pig hearts, producing a local partial stenosis and interacting like the atherosclerotic plaque by stretching and shrinking with the vessel wall and surrounding tissue. This artificial atherosclerotic plaque model works as a simulating tool for future medical testing and could be crucial for further specified research on coronary artery disease and is going to help to provide information about the optimal interventional and surgical care of the disease.

Sections du résumé

BACKGROUND BACKGROUND
Experimental coronary artery interventions are currently being performed on non-diseased blood vessels in healthy animals. To provide a more realistic pathoanatomical scenario for investigations on novel interventional and surgical therapies, we aimed to fabricate a stenotic lesion, mimicking the morphology and structure of a human atherosclerotic plaque.
METHODS METHODS
In an interdisciplinary setting, we engineered a casting mold to create an atherosclerotic plaque with the dimensions to fit in a porcine coronary artery. Oscillatory rheology experiments took place along with long-term stability tests assessed by microscopic examination and weight monitoring. For the implantability in future in vivo setups, we performed a cytotoxicity assessment, inserted the plaque in resected pig hearts, and performed diagnostic imaging to visualize the plaque in its final position.
RESULTS RESULTS
The most promising composition consists of gelatin, cholesterol, phospholipids, hydroxyapatite, and fine-grained calcium carbonate. It can be inserted in the coronary artery of human-sized pig hearts, producing a local partial stenosis and interacting like the atherosclerotic plaque by stretching and shrinking with the vessel wall and surrounding tissue.
CONCLUSION CONCLUSIONS
This artificial atherosclerotic plaque model works as a simulating tool for future medical testing and could be crucial for further specified research on coronary artery disease and is going to help to provide information about the optimal interventional and surgical care of the disease.

Identifiants

pubmed: 38667208
pii: biomimetics9040197
doi: 10.3390/biomimetics9040197
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Philipp Lindenhahn (P)

Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30559 Hannover, Germany.
Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hanover, 30559 Hannover, Germany.

Jannik Richter (J)

Institute of Technical Chemistry, Leibniz University of Hannover, 30167 Hannover, Germany.

Iliyana Pepelanova (I)

Institute of Technical Chemistry, Leibniz University of Hannover, 30167 Hannover, Germany.

Bettina Seeger (B)

Institute for Food Quality and Food Safety, University of Veterinary Medicine, 30559 Hannover, Germany.

Holger A Volk (HA)

Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hanover, 30559 Hannover, Germany.

Rabea Hinkel (R)

Department of Laboratory Animal Science, Leibnitz-Institut für Primatenforschung, Deutsches Primatenzentrum GmbH, Kellnerweg 4, 37077 Göttingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, 37075 Göttingen, Germany.
Institute for Animal Hygiene, Animal Welfare and Farm Animal Behavior, University of Veterinary Medicine, 30559 Hannover, Germany.

Bernhard Hiebl (B)

Institute for Animal Hygiene, Animal Welfare and Farm Animal Behavior, University of Veterinary Medicine, 30559 Hannover, Germany.

Thomas Scheper (T)

Institute of Technical Chemistry, Leibniz University of Hannover, 30167 Hannover, Germany.

Jan B Hinrichs (JB)

Department of Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Lena S Becker (LS)

Department of Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Axel Haverich (A)

Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30559 Hannover, Germany.

Tim Kaufeld (T)

Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30559 Hannover, Germany.

Classifications MeSH